| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Jul―07 |
Pharmacoepidemiologic and clinical rationale for the inclusion of L-arginine and dihydroquercetin in the combined pharmacotherapy of hypertensive patients with COVID-19 |
Elena N. Naletova, Olga S. Naletova, Elena B. Serdyuk, Sergey V. Naletov, Mikhail M. Alesinsky, Inna A. Sidorenko, Tatyana A. Tverdokhleb |
| 2 |
[GO] |
2023―Jun―22 |
The therapeutic potential of mesenchymal stem cells in COVID-19: Present and future |
Mutiara Indah Sari, Imam Budi Putra, Dadik Wahyu Wijaya |
| 3 |
[GO] |
2023―Apr―28 |
Impact of COVID-19 on clinical trials protocol amendments |
Anastasia Eleskina, Olga V. Filippova, Nathalia V. Pyatigorskaya |
| 4 |
[GO] |
2020―Dec―29 |
Possible prospects for using modern magnesium preparations for increasing stress resistance during COVID-19 pandemic |
Maria V. Sankova, Olesya V. Kytko, Renata D. Meylanova, Yuriy L. Vasil’ev, Michael V. Nelipa |
| 5 |
[GO] |
2020―May―04 |
On the way from SARS-CoV-sensitive mice to murine COVID-19 model |
Vladislav O. Soldatov, Marina V. Kubekina, Yulia Yu. Silaeva, Alexandra V. Bruter, Alexey V. Deykin |
